Navigation Links
Protalix BioTherapeutics to Present at Two Upcoming Healthcare Conferences
Date:10/25/2010

er, the Company's President and Chief Executive Officer, will present at the Oppenheimer 21st Annual Healthcare Conference in New York and the World Orphan Drug Congress 2010 in Geneva. The conference schedule is as follows:Oppenheimer 21st Annual Healthcare ConferenceCorporate Presentation, November 2 at 12:00 PM ETWaldorf Astoria Hotel, New York, NYA webcast of this presentation will be available at www.protalix.com on the event calendar pageWorld Orphan Drug Congress 2010Presentation, November 30 at 9:10 AM CESTCrown Plaza Hotel, Geneva, SwitzerlandAbout ProtalixProtalix is a biopharmaceutical company focused on the development and commercialization of proprietary recombinant therapeutic proteins expressed through its proprietary plant cell based expression system.  Protalix's ProCellEx™ presents a proprietary method for the expression of recombinant proteins that Protalix believes will allow for the cost-effective, industrial-scale production of recombinant therapeutic proteins in an environment free of mammalian components and viruses.  Protalix is also advancing additional recombinant biopharmaceutical drug development programs.  Taliglucerase alfa is an enzyme replacement therapy in development under a Special Protocol Assessment with the FDA for Gaucher disease. The Company's new drug application (NDA) for taliglucerase alfa has been accepted by the U.S. Food and Drug Administration (FDA) and granted a Prescription Drug User Fee Act (PDUFA) action date of February 25, 2011.

Investor Contact: Marcy NanusThe Trout Group, LLCTelephone: 646-378-2927Email: mnanus@troutgroup.com
'/>"/>

SOURCE Protalix BioTherapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs
2. Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study
3. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
4. Talecris Biotherapeutics Receives FDA Approval for Gamunex®-C
5. Talecris Biotherapeutics to Report Third Quarter 2010 Financial Results
6. Talecris Biotherapeutics CEO Accepts 2010 Ernst & Young Entrepreneur Of The Year Award on Behalf of Employees and Patients
7. Garnet BioTherapeutics Announces First Patient Treated in Trial of New Therapy for Improvement in Scar Appearance
8. NASDAQ Trading for Oxygen Biotherapeutics, Inc. Shares to Begin January 15, 2010
9. Oxygen Biotherapeutics, Inc. Announces Approval for NASDAQ Listing
10. Oxygen Biotherapeutics, Inc. Expands Board of Directors
11. Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 19, 2014  CytRx Corporation (Nasdaq: CYTR ... oncology, today announced that David J. Haen , ... NewsMakers in the Biotech Industry Conference on Friday, September 26 ... will take place at the Millennium Broadway Hotel in ... A live and archived webcast of the presentation will ...
(Date:9/19/2014)... 19, 2014 Reductions in kidney ... years in people with diabetes type 2 ... benefits for the kidneys." Australian researchers have ... 2 diabetes leads to persistent reductions in kidney failure ... The global study has found that, five and a ...
(Date:9/18/2014)... ... announced the addition of the "Global ... their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... chromosomes using molecular biology to understand the ... It plays a crucial role in the ...
Breaking Medicine Technology:CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 3ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 2ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 3Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 2Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 3
... TRIANGLE PARK, N.C. , June 2 ... it has received a letter from the U.S. Food ... its respiratory products Serevent® and Advair®.  The letter concludes ... committee meetings regarding the safety profile of long-acting beta2-agonists ...
... June 2 The Georgia Advanced Surgery ... first fully accredited surgical center for performing all ... true outpatient setting – has officially opened. ... highly advanced, minimally invasive surgical techniques that spare ...
Cached Medicine Technology:GSK Announces Revised Product Labels for Serevent® and Advair® 2New Georgia Advanced Surgery Center Provides Women Many Unique Benefits 2
(Date:9/20/2014)... Final Cut Pro X Plugin developers ... Information theme for FCPX filmmakers. , “Fun, cool, and simple ... theme,” says Christina Austin, CEO of Pixel Film Studios. “It ... Information features easy to use controls that give the user ... the background color, color of each circle outline, the position ...
(Date:9/20/2014)... 20, 2014 The children of Branches ... and active play they need. An empty lot at ... Lakeview Campus was transformed into a kid-designed playspace in ... volunteers from Branches (@BranchesFL), ESPN (@TeamESPN), Disney (@CitizenDisney), area ... believes a playground is more than a playground. It’s ...
(Date:9/19/2014)... Kansas City, KS (PRWEB) September 19, 2014 ... City, is responding to families in regions of the Philippines ... volcano. , More than 1,060 families evacuated to the ... tropical storm Fung-Wong brought heavy rain and gusty winds to ... Metro-Manila Friday causing heavy flooding. Some homes filled with more ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 Hastings and Hastings, ... years in the industry, announces a record number of visitors ... a wide variety of serious injury cases as well as ... with dog bite related accident cases and others. Having served ... Hastings has stood the test of time when it comes ...
(Date:9/19/2014)... Sept. 19, 2014 (HealthDay News) -- U.S. military troops ... of skin cancer, according to a new study. ... abroad, researchers revealed. In some cases, military personnel developed ... the color, shape or size of their moles since ... be risk factors for skin cancer, the study authors ...
Breaking Medicine News(10 mins):Health News:Today Pixel Film Studios Announced the Release of the Information Theme for Final Cut Pro X 2Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 2Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 3Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 4Health News:Double Threat in Philippines Displaces Thousands of Unbound Families 2Health News:Hastings And Hastings Announces a Record Number of Visitors to Its New Phoenix Personal Injury Website 2Health News:Some U.S. Troops May Face Greater Skin Cancer Risk 2
... blood pressure causes inactivation of nitric oxide, a hormone ... If high blood pressure is left untreated, it does ... spiral out of control. According to the researchers at ... rats and found that nitric oxide, which helps control ...
... men suffering from eating disorders. Men who suffer from ... with the same problems, researchers say.// ,Eating ... which become dangerously thin and brittle. This is linked ... particularly calcium.Low bone mineral density (BMD) can lead to ...
... patients who drink in moderation – between one and ... strokes than either abstainers or heavier drinkers who consume ... researchers. ,Dr Kenneth Mukamal and colleagues at Beth ... alcohol consumption among elderly patients appeared to protect against ...
... is not as accurate as first thought, says research. ,Their ... system worked reasonably well for children whose parents were of ... was "misleading".// ,In fact, children of very tall ... worked out for them, and children of extremely short parents ...
... who suffer from constipation are nearly three times more likely ... Robert Frank, Professor of Biostatistics and Statistics at the University ... Parkinson's was noted almost 2 centuries back from a clinical ... one bowel movement per day. This study is part of ...
... have identified a growth factor that triggers blood ... Dr. Jennifer of Genentech Inc. and colleagues reported ... factor, or EG-VEGF. The finding could lead the ... The endocrine glands produce various hormones such as ...
Cached Medicine News:
... Inverness Medical Professional Diagnostics is a ... extensive IFA and DFA test menu that ... and STDs as well as miscellaneous conjugates ... give you a wide assortment of substrates ...
Anti-Skin Antibody (ASA) Test Kit: Pemphigus and Bullous Pemphigoid...
... Diagnostics is a leading provider of immunofluorescence ... test menu that includes kits for autoimmune ... as miscellaneous conjugates and components. Our Impact ... assortment of substrates and kit sizes to ...
... With advanced glass technologies and designs, ... high magnification views of the posterior ... provide image quality previously unattainable with ... for more detailed and comprehensive views, ...
Medicine Products: